Histona desacetilase (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Histona desacetilase" in Galician language version.

refsWebsite

Global rank Galician rank

25nih.gov

4^th place

6^th place

22doi.org

2^nd place

7^th place

1sciencemag.org

857^th place

242^nd place

1worldcat.org

5^th place

11^th place

1bbc.co.uk

8^th place

31^st place

1clinicaltrials.gov

5,225^th place

7,257^th place

1elsevier.com

610^th place

214^th place

bbc.co.uk

news.bbc.co.uk

"Scientists 'reverse' memory loss". BBC News. 29-04-2007. Consultado o 08-07-2007.

clinicaltrials.gov

Depletion of Latent HIV in CD4 Cells - Full Text View - ClinicalTrials.gov

doi.org

dx.doi.org

Choudhary C; et al. (2009). "Lysine acetylation targets protein complexes and co-regulates major cellular functions". Science 325 (5942): 834–40. ISSN 1095-9203. PMID 19608861. doi:10.1126/science.1175371.
Yang XJ, Seto E (2007). "HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention". Oncogene 26: 5310–5318. PMID 17694074. doi:10.1038/sj.onc.1210599.
Leipe DD, Landsman D (1997). "Histone deacetylases, acetoin utilization proteins and acetylpolyamine amidohydrolases are members of an ancient protein superfamily". Nucleic Acids Res. 25 (18): 3693–7. PMC 146955. PMID 9278492. doi:10.1093/nar/25.18.3693.
Dokmanovic M, Clarke C, Marks PA (2007). "Histone deacetylase inhibitors: overview and perspectives". Mol. Cancer Res. 5 (10): 981–9. PMID 17951399. doi:10.1158/1541-7786.MCR-07-0324.
Sengupta N, Seto E (2004). "Regulation of histone deacetylase activities". J. Cell. Biochem. 93 (1): 57–67. PMID 15352162. doi:10.1002/jcb.20179.
Barneda-Zahonero B, Parra M (August 2012). "Histone deacetylases and cancer". Mol. Oncol. 6 (6): 579–89. PMID 22963873. doi:10.1016/j.molonc.2012.07.003.
Marks PA, Xu WS (July 2009). "Histone Deacetylase Inhibitors: Potential in Cancer Therapy". J. Cell. Biochem. 107 (4): 600–8. PMC 2766855. PMID 19459166. doi:10.1002/jcb.22185.
de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB (2003). "Histone deacetylases (HDACs): characterization of the classical HDAC family". Biochem. J. 370 (Pt 3): 737–49. PMC 1223209. PMID 12429021. doi:10.1042/BJ20021321.
Longworth MS, Laimins LA (2006). "Histone deacetylase 3 localizes to the plasma membrane and is a substrate of Src". Oncogene 25 (32): 4495–500. PMID 16532030. doi:10.1038/sj.onc.1209473.
Valenzuela-Fernández A, Cabrero JR, Serrador JM, Sánchez-Madrid F (2008). "HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions". Trends Cell Biol. 18 (6): 291–7. PMID 18472263. doi:10.1016/j.tcb.2008.04.003.
Zupkovitz G, Tischler J, Posch M; et al. (2006). "Negative and positive regulation of gene expression by mouse histone deacetylase 1". Mol. Cell. Biol. 26 (21): 7913–28. PMID 16940178. doi:10.1128/MCB.01220-06.
Sharma RP, Grayson DR, Gavin DP (2007). "Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: Analysis of the National Brain Databank microarray collection". Schizophrenia Research 98: 111. PMID 17961987. doi:10.1016/j.schres.2007.09.020.
Glozak MA, Sengupta N, Zhang X, Seto E (2005). "Acetylation and deacetylation of non-histone proteins". Gene 363: 15–23. PMID 16289629. doi:10.1016/j.gene.2005.09.010.
Rodriguez-Gonzalez A, Lin T, Ikeda AK, Simms-Waldrip T, Fu C, Sakamoto KM (2008). "Role of the aggresome pathway in cancer: targeting histone deacetylase 6-dependent protein degradation". Cancer Res. 68 (8): 2557–60. PMID 18413721. doi:10.1158/0008-5472.CAN-07-5989.
Ikenoue T, Inoki K, Zhao B, Guan KL (2008). "PTEN acetylation modulates its interaction with PDZ domain". Cancer Res. 68 (17): 6908–12. PMID 18757404. doi:10.1158/0008-5472.CAN-08-1107.
Bhakat KK, Izumi T, Yang SH, Hazra TK, Mitra S (2003). "Role of acetylated human AP-endonuclease (APE1/Ref-1) in regulation of the parathyroid hormone gene". Embo J. 22 (23): 6299–309. PMID 14633989. doi:10.1093/emboj/cdg595.
Fantini D, Vascotto C, Deganuto M, Bivi N, Gustincich S, Marcon G, Quadrifoglio F, Damante G, Bhakat KK, Mitra S, Tell G (2008). "APE1/Ref-1 regulates PTEN expression mediated by Egr-1". Free Radic Res. 42 (1): 20–9. PMID 18324520. doi:10.1080/10715760701765616.
Hasselgren PO (2007). "Ubiquitination, phosphorylation, and acetylation--triple threat in muscle wasting". J Cell Physiol. 213 (3): 679–89. PMID 17657723. doi:10.1002/jcp.21190.
Hahnen E, Hauke J, Tränkle C, Eyüpoglu IY, Wirth B, Blümcke I (2008). "Histone deacetylase inhibitors: possible implications for neurodegenerative disorders". Expert Opin Investig Drugs 17 (2): 169–84. PMID 18230051. doi:10.1517/13543784.17.2.169.
Monneret C (2007). "Histone deacetylase inhibitors for epigenetic therapy of cancer". Anticancer Drugs 18 (4): 363–70. PMID 17351388. doi:10.1097/CAD.0b013e328012a5db.
Drummond DC, Noble CO, Kirpotin DB, Guo Z, Scott GK, Benz CC (2005). "Clinical development of histone deacetylase inhibitors as anticancer agents". Annu Rev Pharmacol Toxicol 45: 495–528. PMID 15822187. doi:10.1146/annurev.pharmtox.45.120403.095825.
Arbuckle, Jesse. "The molecular biology of human herpesvirus-6 latency and telomere integration". Microbes and infection 13 (8-9): 731–741. PMC 3130849. PMID 21458587. doi:10.1016/j.micinf.2011.03.006.

elsevier.com

linkinghub.elsevier.com

Batty N (2009). "Histone deacetylase inhibitors as anti-neoplastic agents". Cancer Letters 280 (2): 190–200. PMID 19345475.

nih.gov

ncbi.nlm.nih.gov

Bottomley, M. J.; Lo Surdo, P.; Di Giovine, P.; Cirillo, A.; Scarpelli, R.; Ferrigno, F.; Jones, P.; Neddermann, P.; De Francesco, R.; Steinkühler, C.; Gallinari, P.; Carfí, A. (2008). "Structural and Functional Analysis of the Human HDAC4 Catalytic Domain Reveals a Regulatory Structural Zinc-binding Domain". Journal of Biological Chemistry 283 (39): 26694–26704. doi:10.1074/jbc.M803514200. PMC 3258910. PMID 18614528.
Choudhary C; et al. (2009). "Lysine acetylation targets protein complexes and co-regulates major cellular functions". Science 325 (5942): 834–40. ISSN 1095-9203. PMID 19608861. doi:10.1126/science.1175371.
Yang XJ, Seto E (2007). "HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention". Oncogene 26: 5310–5318. PMID 17694074. doi:10.1038/sj.onc.1210599.
Leipe DD, Landsman D (1997). "Histone deacetylases, acetoin utilization proteins and acetylpolyamine amidohydrolases are members of an ancient protein superfamily". Nucleic Acids Res. 25 (18): 3693–7. PMC 146955. PMID 9278492. doi:10.1093/nar/25.18.3693.
Dokmanovic M, Clarke C, Marks PA (2007). "Histone deacetylase inhibitors: overview and perspectives". Mol. Cancer Res. 5 (10): 981–9. PMID 17951399. doi:10.1158/1541-7786.MCR-07-0324.
Sengupta N, Seto E (2004). "Regulation of histone deacetylase activities". J. Cell. Biochem. 93 (1): 57–67. PMID 15352162. doi:10.1002/jcb.20179.
Barneda-Zahonero B, Parra M (August 2012). "Histone deacetylases and cancer". Mol. Oncol. 6 (6): 579–89. PMID 22963873. doi:10.1016/j.molonc.2012.07.003.
Marks PA, Xu WS (July 2009). "Histone Deacetylase Inhibitors: Potential in Cancer Therapy". J. Cell. Biochem. 107 (4): 600–8. PMC 2766855. PMID 19459166. doi:10.1002/jcb.22185.
de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB (2003). "Histone deacetylases (HDACs): characterization of the classical HDAC family". Biochem. J. 370 (Pt 3): 737–49. PMC 1223209. PMID 12429021. doi:10.1042/BJ20021321.
Longworth MS, Laimins LA (2006). "Histone deacetylase 3 localizes to the plasma membrane and is a substrate of Src". Oncogene 25 (32): 4495–500. PMID 16532030. doi:10.1038/sj.onc.1209473.
Valenzuela-Fernández A, Cabrero JR, Serrador JM, Sánchez-Madrid F (2008). "HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions". Trends Cell Biol. 18 (6): 291–7. PMID 18472263. doi:10.1016/j.tcb.2008.04.003.
Zupkovitz G, Tischler J, Posch M; et al. (2006). "Negative and positive regulation of gene expression by mouse histone deacetylase 1". Mol. Cell. Biol. 26 (21): 7913–28. PMID 16940178. doi:10.1128/MCB.01220-06.
Sharma RP, Grayson DR, Gavin DP (2007). "Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: Analysis of the National Brain Databank microarray collection". Schizophrenia Research 98: 111. PMID 17961987. doi:10.1016/j.schres.2007.09.020.
Glozak MA, Sengupta N, Zhang X, Seto E (2005). "Acetylation and deacetylation of non-histone proteins". Gene 363: 15–23. PMID 16289629. doi:10.1016/j.gene.2005.09.010.
Rodriguez-Gonzalez A, Lin T, Ikeda AK, Simms-Waldrip T, Fu C, Sakamoto KM (2008). "Role of the aggresome pathway in cancer: targeting histone deacetylase 6-dependent protein degradation". Cancer Res. 68 (8): 2557–60. PMID 18413721. doi:10.1158/0008-5472.CAN-07-5989.
Ikenoue T, Inoki K, Zhao B, Guan KL (2008). "PTEN acetylation modulates its interaction with PDZ domain". Cancer Res. 68 (17): 6908–12. PMID 18757404. doi:10.1158/0008-5472.CAN-08-1107.
Yao XH, Nyomba BL (2008). "Hepatic insulin resistance induced by prenatal alcohol exposure is associated with reduced PTEN and TRB3 acetylation in adult rat offspring". Am J Physiol Regul Integr Comp Physiol 294 (6): R1797–806. PMID 18385463.
Bhakat KK, Izumi T, Yang SH, Hazra TK, Mitra S (2003). "Role of acetylated human AP-endonuclease (APE1/Ref-1) in regulation of the parathyroid hormone gene". Embo J. 22 (23): 6299–309. PMID 14633989. doi:10.1093/emboj/cdg595.
Fantini D, Vascotto C, Deganuto M, Bivi N, Gustincich S, Marcon G, Quadrifoglio F, Damante G, Bhakat KK, Mitra S, Tell G (2008). "APE1/Ref-1 regulates PTEN expression mediated by Egr-1". Free Radic Res. 42 (1): 20–9. PMID 18324520. doi:10.1080/10715760701765616.
Hasselgren PO (2007). "Ubiquitination, phosphorylation, and acetylation--triple threat in muscle wasting". J Cell Physiol. 213 (3): 679–89. PMID 17657723. doi:10.1002/jcp.21190.
Hahnen E, Hauke J, Tränkle C, Eyüpoglu IY, Wirth B, Blümcke I (2008). "Histone deacetylase inhibitors: possible implications for neurodegenerative disorders". Expert Opin Investig Drugs 17 (2): 169–84. PMID 18230051. doi:10.1517/13543784.17.2.169.
Monneret C (2007). "Histone deacetylase inhibitors for epigenetic therapy of cancer". Anticancer Drugs 18 (4): 363–70. PMID 17351388. doi:10.1097/CAD.0b013e328012a5db.
Batty N (2009). "Histone deacetylase inhibitors as anti-neoplastic agents". Cancer Letters 280 (2): 190–200. PMID 19345475.
Drummond DC, Noble CO, Kirpotin DB, Guo Z, Scott GK, Benz CC (2005). "Clinical development of histone deacetylase inhibitors as anticancer agents". Annu Rev Pharmacol Toxicol 45: 495–528. PMID 15822187. doi:10.1146/annurev.pharmtox.45.120403.095825.
Arbuckle, Jesse. "The molecular biology of human herpesvirus-6 latency and telomere integration". Microbes and infection 13 (8-9): 731–741. PMC 3130849. PMID 21458587. doi:10.1016/j.micinf.2011.03.006.

sciencemag.org

Choudhary C; et al. (2009). "Lysine acetylation targets protein complexes and co-regulates major cellular functions". Science 325 (5942): 834–40. ISSN 1095-9203. PMID 19608861. doi:10.1126/science.1175371.

worldcat.org

Choudhary C; et al. (2009). "Lysine acetylation targets protein complexes and co-regulates major cellular functions". Science 325 (5942): 834–40. ISSN 1095-9203. PMID 19608861. doi:10.1126/science.1175371.